Coexpression of PD-L1/PD-1 with CXCR3/CD36 and IL-19 Increase in Extranodal Lymphoma

Figure 5

ROC curves of PD-L1/PD-1 coexpression with CXCR3/CD36 and IL-19 to diagnose extranodal involvement in lymphoma. (a) Posttherapy CXCR3+%. (b) Posttherapy PD-L1+CXCR3+%. (c) Posttherapy PD-1+CXCR3%. (d) Posttherapy CD36+%. (e) Posttherapy PD-L1+CD36%. (f) Posttherapy PD-1+CD36%. (g) Posttherapy IL-19.

(a)

(b)

(c)

(d)

(e)

(f)

(g)